Novartis To Pay $729M To End 2 FCA Kickback Accusations

By Dave Simpson · July 1, 2020, 11:53 PM EDT

Novartis Pharmaceuticals Corp. has agreed to pay more than $729 million to end two separate sets of allegations from the U.S. Department of Justice that it violated the False Claims Act...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

United States Of America v. Novartis Pharmaceuticals Corporation

Case Number

Court

New York Southern

Nature of Suit

Other Statutory Actions

Date Filed

January 05, 2011

Recent Articles By Dave

January 30, 2023
Feds Call Convicted Theranos COO Balwani A 'Flight Risk'
December 14, 2022
Health Net Hit With $14.4M Verdict Over Surgery Delay
December 13, 2022
DeSantis Petitions Fla. Justices For COVID-19 Vax Grand Jury
December 12, 2022
Juul To Pay Pa. $38.8M To Settle Youth Marketing Claims
December 05, 2022
Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
December 02, 2022
Doctor Repped By RFK Jr. Targets COVID Misinformation Law
November 18, 2022
DOJ Will Ask DC Circ. To Block UnitedHealth-Change Deal
November 17, 2022
Akin Gump Gets Green Light To Represent Endo Claimants
November 04, 2022
SF-Walgreens Opioid Trial Called Off Amid Settlement Talks
October 31, 2022
Direct HIV Med Buyers Seek OK Of $10.8M Bristol-Myers Deal